Ignite Creation Date:
2024-05-06 @ 4:00 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04835844
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2021-03-25
Brief Title:
RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation
Sponsor:
The Cleveland Clinic
Organization:
The Cleveland Clinic
Study Overview
Official Title:
RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation MAP-AF Study
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MAP-AF
Brief Summary:
The MAP-AF study will compare RHYTHMIA vs CARTO in redo ablation of paroxysmal AF with assessment of both acute procedural profiles and clinical outcomes
Detailed Description:
Pulmonary venous conduction recovery is found in most patients undergoing redo ablation procedures for atrial fibrillation AF Identifying gaps in prior ablation lines is essential to achieve successful outcomes High density mapping systems have been proposed to allow the identification of such gaps with speed and accuracy
The MAP-AF study will compare RHYTHMIA vs CARTO in redo ablation of paroxysmal AF with assessment of both acute procedural profiles and clinical outcomes
The MAP-AF study will compare RHYTHMIA vs CARTO in redo ablation of paroxysmal AF with assessment of both acute procedural profiles and clinical outcomes
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None